Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Stoops · SciRah

Researcher profile · Semantic Scholar

E. Stoops

Share profile

E. Stoops — researcher profile on SciRah

h-index: 33
Works: 144
Citations: 4,435

Most-cited papers

Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease
S. Janelidze, Divya Bali, N. Ashton, N. Barthélemy +13 more
2022Brain : a journal of neurology461 citations Open access
Semantic Scholar
Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
P. Chatterjee, S. Pedrini, E. Stoops, Kathryn Goozee +11 more
2021Translational Psychiatry369 citations Open access
Semantic Scholar
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected
M. Suárez-Calvet, T. Karikari, N. Ashton, Juan Lantero Rodríguez +37 more
2020EMBO Molecular Medicine366 citations Open access
Semantic Scholar
Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
I. Verberk, Elisabeth H. Thijssen, Jannet Koelewijn, Kimberley Mauroo +12 more
2020Alzheimer's Research & Therapy233 citations Open access
Semantic Scholar
Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays
N. Ashton, Albert Puig-Pijoan, M. Milà-Alomà, A. Fernández-Lebrero +27 more
2022Alzheimer's & Dementia210 citations Open access
Semantic Scholar
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
Sherif Bayoumy, I. W. Verberk, Ben den Dulk, Zulaiga Hussainali +10 more
2021Alzheimer's Research & Therapy174 citations Open access
Semantic Scholar
Parkinson’s disease biomarkers based on α‐synuclein
M. Fayyad, Safa Salim, N. Majbour, D. Erskine +3 more
2019Journal of Neurochemistry142 citations Open access
Semantic Scholar
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease
N. Ashton, A. Benedet, T. Pascoal, T. Karikari +14 more
2022EBioMedicine133 citations Open access
Semantic Scholar
Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology: How specific are the conformation-specific α-synuclein antibodies?
Senthil T. Kumar, Somanath Jagannath, Cindy François, H. Vanderstichele +2 more
2020bioRxiv121 citations Open access
Semantic Scholar
Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis
Steffi De Meyer, J. Schaeverbeke, I. Verberk, B. Gille +11 more
2020Alzheimer's Research & Therapy92 citations Open access
Semantic Scholar
Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia
Elisabeth H. Thijssen, I. W. Verberk, J. Kindermans, Adlin Abramian +8 more
2022Alzheimer's & Dementia89 citations Open access
Semantic Scholar
Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays
Niccolò Candelise, M. Schmitz, Katrin Thüne, M. Cramm +7 more
2020Translational Neurodegeneration79 citations Open access
Semantic Scholar
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho‐tau Round Robin study
N. Ashton, A. Keshavan, W. Brum, U. Andreasson +40 more
2025Alzheimer's & Dementia75 citations Open access
Semantic Scholar
Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer’s disease
Elisabeth H. Thijssen, I. W. Verberk, Jeroen Vanbrabant, A. Koelewijn +6 more
2020Scientific Reports68 citations Open access
Semantic Scholar
C-Reactive Protein, Plasma Amyloid-&bgr; Levels, and Their Interaction With Magnetic Resonance Imaging Markers
S. Hilal, M. Ikram, M. Verbeek, O. Franco +4 more
2018Stroke65 citations Open access
Semantic Scholar
Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity
H. Lashuel, Anne-Laure Mahul-Mellier, S. Novello, R. N. Hegde +13 more
2022npj Parkinson's Disease55 citations Open access
Semantic Scholar
First amyloid β1‐42 certified reference material for re‐calibrating commercial immunoassays
S. Boulo, J. Kuhlmann, U. Andreasson, Britta Brix +32 more
2020Alzheimer's & Dementia54 citations Open access
Semantic Scholar
Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin study
B. Mollenhauer, F. Bowman, D. Drake, Jimmy Duong +20 more
2018Journal of Neurochemistry50 citations Open access
Semantic Scholar
Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study
S. Hilal, F. Wolters, M. Verbeek, H. Vanderstichele +4 more
2018Alzheimer's Research & Therapy48 citations Open access
Semantic Scholar
Decreased cerebrospinal fluid Aβ 38, 40, 42, and 43 levels in sporadic and hereditary cerebral amyloid angiopathy
A. D. de Kort, H. B. Kuiperij, Tainá M. Marques, Lieke Jäkel +18 more
2023Annals of Neurology37 citations Open access
Semantic Scholar
Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements
U. Andreasson, J. Kuhlmann, Josef Pannee, R. Umek +11 more
2018Clinical Chemistry and Laboratory Medicine37 citations Open access
Semantic Scholar
Plasma p‐tau181/Aβ1‐42 ratio predicts Aβ‐PET status and correlates with CSF‐p‐tau181/Aβ1‐42 and future cognitive decline
C. Fowler, E. Stoops, S. Rainey-Smith, E. Vanmechelen +12 more
2022medRxiv36 citations Open access
Semantic Scholar
The global Alzheimer's Association round robin study on plasma amyloid β methods
Josef Pannee, L. Shaw, M. Korecka, T. Waligórska +31 more
2021Alzheimer's & Dementia36 citations Open access
Semantic Scholar
Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease
Y. Hok-A-Hin, M. del Campo, Walter A. Boiten, E. Stoops +4 more
2023Journal of Neuroinflammation33 citations Open access
Semantic Scholar
Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET
Steffi De Meyer, J. Schaeverbeke, E. Luckett, Mariska Reinartz +13 more
2024Brain Communications28 citations Open access
Semantic Scholar
Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy
M. Schmitz, Anna Villar-Piqué, F. Llorens, K. Gmitterová +10 more
2018Molecular Neurobiology28 citations
Semantic Scholar
Analytical and clinical performance of eight Simoa® and Lumipulse® assays for automated measurement of plasma p-tau181 and p-tau217
A. Wojdała, Jeroen Vanbrabant, Sherif Bayoumy, Daniel Antwi‐Berko +9 more
2024Alzheimer's Research & Therapy27 citations Open access
Semantic Scholar
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer’s disease
N. Ashton, A. Benedet, T. Pascoal, T. Karikari +13 more
202127 citations Open access
Semantic Scholar
Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adults
Jun Yuan, S. Pedrini, R. Thota, J. Doecke +20 more
2023npj Aging26 citations Open access
Semantic Scholar
Phospho‐specific plasma p‐tau181 assay detects clinical as well as asymptomatic Alzheimer's disease
Steffi De Meyer, Jeroen Vanbrabant, J. Schaeverbeke, Mariska Reinartz +7 more
2022Annals of Clinical and Translational Neurology26 citations Open access
Semantic Scholar
Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo
Tobias Thom, M. Schmitz, Anna-Lisa Fischer, A. Correia +11 more
2021Movement Disorders22 citations Open access
Semantic Scholar
Plasma A&bgr; (Amyloid-&bgr;) Levels and Severity and Progression of Small Vessel Disease
E. V. van Leijsen, H. B. Kuiperij, Iris Kersten, M. Bergkamp +7 more
2018Stroke21 citations
Semantic Scholar
Plasma Amyloid-Beta Levels in a Pre-Symptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy Pedigree: A Cross-Sectional and Longitudinal Investigation
P. Chatterjee, Michelle Tegg, S. Pedrini, A. Fagan +19 more
2021International Journal of Molecular Sciences20 citations Open access
Semantic Scholar
Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer’s disease, positive for plasma p-tau217
B. Kovačech, Nicholas C. Cullen, Petr Novak, Jozef Hanes +10 more
2024Alzheimer's Research & Therapy19 citations Open access
Semantic Scholar
Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy
I. Rasing, S. Voigt, E. Koemans, A. D. de Kort +14 more
2024Alzheimer's Research & Therapy19 citations Open access
Semantic Scholar
Amyloid, pTau, NfL, and GFAP as biomarkers for Alzheimer’s disease
Elisabeth H. Thijssen, I. W. Verberk, E. Stoops, A. Boxer +1 more
202019 citations Open access
Semantic Scholar
Cerebrospinal ﬂ uid p-tau231 as an early indicator of emerging pathology in Alzheimer ’ s disease
N. Ashton, L. Benedet, T. Pascoal, T. Karikari +14 more
202115 citations
Semantic Scholar
Comparative Analysis of Total Alpha-Synuclein (αSYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified αSYN Proteoforms
Lara Petricca, Nour Chiki, Layane Hanna-El-Daher, Lorène Aeschbach +4 more
2022bioRxiv12 citations Open access
Semantic Scholar
Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
A. D. de Kort, H. B. Kuiperij, D. Alcolea, Iris Kersten +8 more
2021Alzheimer's Research & Therapy12 citations Open access
Semantic Scholar
Cerebrospinal fluid levels of synaptic and neuronal integrity correlate with gray matter volume and amyloid load in the precuneus of cognitively intact older adults
J. Schaeverbeke, B. Gille, Katarzyna Adamczuk, H. Vanderstichele +7 more
2019Journal of Neurochemistry11 citations Open access
Semantic Scholar
Profiling amyloid-β peptides as biomarkers for cerebral amyloid angiopathy
E. van den Berg, Iris Kersten, G. Brinkmalm, Kjell Johansson +11 more
2024Journal of Neurochemistry10 citations Open access
Semantic Scholar
A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms
Joke Verelst, N. Geukens, S. Eddarkaoui, Dorien Vliegen +14 more
2020Frontiers in Molecular Biosciences10 citations Open access
Semantic Scholar
Plasma biomarkers predict amyloid pathology in cognitively normal monozygotic twins after 10 years
A. den Braber, I. W. Verberk, J. Tomassen, Ben den Dulk +11 more
2023Brain Communications8 citations Open access
Semantic Scholar
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement
Silvia Paciotti, E. Stoops, Cindy François, G. Bellomo +4 more
2021Clinical Chemistry and Laboratory Medicine8 citations
Semantic Scholar
Automation on an Open-Access Platform of Alzheimer’s Disease Biomarker Immunoassays
B. Gille, L. Dedeene, E. Stoops, Leentje Demeyer +8 more
2018SLAS technology7 citations Open access
Semantic Scholar
An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration
M. Honey, Y. Hok-A-Hin, Elisabeth H. Thijssen, K. Cousins +25 more
2026Nature Medicine6 citations Open access
Semantic Scholar
Serum neuronal pentraxin 2 levels are associated with shorter survival in amyotrophic lateral sclerosis
Soha Alali, Jonas Dubin, F. Hobin, Shreyasee Das +5 more
2025Journal of Neurology Neurosurgery & Psychiatry6 citations Open access
Semantic Scholar
Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease
Erika N. Cline, Daniel Antwi‐Berko, Karen L. Sundell, Elizabeth Johnson +13 more
2025The journal of prevention of Alzheimer's disease6 citations Open access
Semantic Scholar
Preliminary performance of the Lumipulse G pTau 217 Plasma prototype assay on plasma samples
M. Vandijck, F. De Keyser, Charlotte Lambrechts, Yurina Hasumi +10 more
2023Alzheimer's & Dementia5 citations Open access
Semantic Scholar
Phosphorylated α-synuclein in CSF and plasma does not reflect synucleinopathy
G. Bellomo, E. Stoops, Jeroen Vanbrabant, Leentje Demeyer +9 more
2025npj Parkinson's Disease4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Vanderstichele×19
Invite
H. Vanderstichele — researcher profile on SciRah
H. Zetterberg×15
Invite
H. Zetterberg — researcher profile on SciRah
Jeroen Vanbrabant×14
Invite
Jeroen Vanbrabant — researcher profile on SciRah
K. Blennow×14
Invite
K. Blennow — researcher profile on SciRah

×14

Invite

C. Teunissen — researcher profile on SciRah

E. Vanmechelen×13

Invite

E. Vanmechelen — researcher profile on SciRah

Invite

N. Ashton — researcher profile on SciRah

Cindy François×9

Invite

Cindy François — researcher profile on SciRah

Invite

I. Verberk — researcher profile on SciRah

W. M. van der Flier×7

Invite

W. M. van der Flier — researcher profile on SciRah

Invite

M. Verbeek — researcher profile on SciRah

Invite

M. Vandijck — researcher profile on SciRah